These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29635165)

  • 1. Discovery of 6-chloro-2-(propylthio)-8,9-dihydro-7H-purines containing a carboxamide moiety as potential selective anti-lung cancer agents.
    Zhao TQ; Zhao YD; Liu XY; Wang B; Li ZH; He ZX; Zhang XH; Liang JJ; Ma LY; Liu HM
    Eur J Med Chem; 2018 May; 151():327-338. PubMed ID: 29635165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purine derivatives with heterocyclic moieties and related analogs as new antitumor agents.
    Fernández-Sáez N; Rubio-Ruiz B; Campos JM; Unciti-Broceta A; Carrión MD; Camacho ME
    Future Med Chem; 2019 Jan; 11(2):83-95. PubMed ID: 30644318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purines and triazolo[4,3-e]purines containing pyrazole moiety as potential anticancer and antioxidant agents.
    Shaaban OG; Abd El Razik HA; A Shams El-Dine SE; Ashour FA; El-Tombary AA; Afifi OS; Abu-Serie MM
    Future Med Chem; 2018 Jun; 10(12):1449-1464. PubMed ID: 29788781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 2-oxo-4-chloro-1,2-dihydroquinoline-3-carboxamide moiety.
    Tang Q; Zhai X; Tu Y; Wang P; Wang L; Wu C; Wang W; Xie H; Gong P; Zheng P
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1794-8. PubMed ID: 26944614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of 9H-purins as potential tubulin polymerization inhibitors: Synthesis, biological evaluation and structure-activity relationships.
    Zhou ZZ; Shi XD; Feng HF; Cheng YF; Wang HT; Xu JP
    Eur J Med Chem; 2017 Sep; 138():1126-1134. PubMed ID: 28763647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine.
    Caba O; Díaz-Gavilán M; Rodríguez-Serrano F; Boulaiz H; Aránega A; Gallo MA; Marchal JA; Campos JM
    Eur J Med Chem; 2011 Sep; 46(9):3802-9. PubMed ID: 21684047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-proliferative activity of 2,6-dichloro-9- or 7-(ethoxycarbonylmethyl)-9H- or 7H-purines against several human solid tumour cell lines.
    Morales F; Ramírez A; Conejo-García A; Morata C; Marchal JA; Campos JM
    Eur J Med Chem; 2014 Apr; 76():118-24. PubMed ID: 24583351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 3-(2,6,9-trisubstituted-9H-purine)-8-chalcone derivatives as potent anti-gastric cancer agents: Design, synthesis and structural optimization.
    Zhao TQ; Zhao YD; Liu XY; Li ZH; Wang B; Zhang XH; Cao YQ; Ma LY; Liu HM
    Eur J Med Chem; 2019 Jan; 161():493-505. PubMed ID: 30388465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-guided development of purine amide, hydroxamate, and amidoxime for the inhibition of non-small cell lung cancer.
    Huang MR; Hsu YL; Lin TC; Cheng TJ; Li LW; Tseng YW; Chou YS; Liu JH; Pan SH; Fang JM; Wong CH
    Eur J Med Chem; 2019 Nov; 181():111551. PubMed ID: 31376567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anticancer activity of (RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines.
    Conejo-García A; García-Rubiño ME; Marchal JA; Núñez MC; Ramírez A; Cimino S; García MÁ; Aránega A; Gallo MA; Campos JM
    Eur J Med Chem; 2011 Sep; 46(9):3795-801. PubMed ID: 21645946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promising 2,6,9-Trisubstituted Purine Derivatives for Anticancer Compounds: Synthesis, 3D-QSAR, and Preliminary Biological Assays.
    O Salas C; Zarate AM; Kryštof V; Mella J; Faundez M; Brea J; Loza MI; Brito I; Hendrychová D; Jorda R; Cabrera AR; Tapia RA; Espinosa-Bustos C
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549.
    Bistrović A; Grbčić P; Harej A; Sedić M; Kraljević-Pavelić S; Koštrun S; Plavec J; Makuc D; Raić-Malić S
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):271-285. PubMed ID: 29271659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
    Zhou P; Huang L; Zhou J; Jiang B; Zhao Y; Deng X; Zhao Q; Li F
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4185-4189. PubMed ID: 28757067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of thiazolo[5,4-d]pyrimidine derivatives as potent antiproliferative agents through the drug repurposing strategy.
    Li ZH; Zhang J; Liu XQ; Geng PF; Ma JL; Wang B; Zhao TQ; Zhao B; Wei HM; Wang C; Fu DJ; Yu B; Liu HM
    Eur J Med Chem; 2017 Jul; 135():204-212. PubMed ID: 28456031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents.
    Shi YK; Wang B; Shi XL; Zhao YD; Yu B; Liu HM
    Eur J Med Chem; 2018 Feb; 145():11-22. PubMed ID: 29310026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues.
    Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM
    Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety.
    Geng PF; Liu XQ; Zhao TQ; Wang CC; Li ZH; Zhang J; Wei HM; Hu B; Ma LY; Liu HM
    Eur J Med Chem; 2018 Feb; 146():147-156. PubMed ID: 29407946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and preliminary biological evaluation of 5,8-dihydropteridine-6,7-diones that induce apoptosis and suppress cell migration.
    Geng PF; Wang CC; Li ZH; Hu XN; Zhao TQ; Fu DJ; Zhao B; Yu B; Liu HM
    Eur J Med Chem; 2018 Jan; 143():1959-1967. PubMed ID: 29133051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel 7-amino-[1,2,4]triazolo[4,3-f]pteridinone, and 7-aminotetrazolo[1,5-f]pteridinone derivative as potent antitumor agents.
    Hou Y; Zhu L; Li Z; Shen Q; Xu Q; Li W; Liu Y; Gong P
    Eur J Med Chem; 2019 Feb; 163():690-709. PubMed ID: 30572179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel 4-(2-fluorophenoxy)quinoline derivatives bearing 4-oxo-1,4-dihydrocinnoline-3-carboxamide moiety as c-Met kinase inhibitors.
    Li S; Zhao Y; Wang K; Gao Y; Han J; Cui B; Gong P
    Bioorg Med Chem; 2013 Jun; 21(11):2843-55. PubMed ID: 23628470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.